Canopy enters U.S. consumer market with new CBD brand



Canopy enters U.S. consumer market with new CBD brand – RICH TV LIVE – DECEMBER 3, 2019 – Canopy Growth Corp. has quietly launched its hemp-derived CBD brand, marking the pot giant’s first official presence in the U.S. consumer market.

Canopy’s new U.S. CBD product brand is dubbed “First & Free” and will be available for sale in 31 U.S. states where CBD products are legally available.

The Smiths Falls, Ont.-based company plans to sell softgels, oil drops, and topical cream products, according to the company’s website. The website’s terms of service page state it’s owned and operated by Canopy Growth and has its servers located in Ontario.

Canopy’s formal entry to the U.S. CBD market comes shortly after the country’s Food and Drug Administration issued a statement last month that it cannot conclude the cannabis compound’s safety in human or animal food products.

“The FDA has seen only limited data about CBD safety and these data point to real risks that need to be considered before taking CBD for any reason,” the U.S. government agency said on its website.

“Some CBD products are being marketed with unproven medical claims and are of unknown quality.”

To address the FDA’s current stance on CBD products, Canopy’s First & Free website comes affixed with a disclaimer that states: “These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.”

Aside from its current product lineup, Canopy has stated its intention to launch CBD products in skincare and cosmetics, vape products, beverages and edibles in the U.S. market, according to financial documents released last month.

A Canopy spokesperson wasn’t immediately available for comment.

Shortly after the FDA’s statement, Jefferies LLC analyst Owen Bennett revised his forecast on the U.S. CBD market, pegging retail sales to reach US$3.5 billion by 2022.

“There will likely be a route to market for CBD products, with the FDA having already approved drugs with CBD as the active ingredient,” Bennett said in a report released last month. “In our view though, the safety risks as well as the spike in consumer interest will likely see heavy regulation, with companies having to support product launches with detailed reports likely including clinical studies.”

Canopy’s new U.S. CBD brand attempts to address some of those health concerns, stating that its products have been “perfected” through its “state-of-the-art technology and rigorous testing.” It also touts it has filed 40 provisional patents, conducted 11 therapeutic trials and has more than 900 patients.

Canopy recently broke ground on a new hemp industrial park in New York where it plans to grow the cannabis-related plant over 2,000 acres in the state. It also has a hemp processing facility in Illinois.

Canopy said earlier this year it planned to open hemp processing facilities in seven U.S. states within the next year.

“We have built our hemp supply chain in the United States through partnering with a diverse group of contract farmers and manufacturers across several states for the cultivation, extraction, processing, and production of hemp-derived products,” the company said in financial documents released last month.

Subscribe – https://www.youtube.com/c/RICHTVLIVE
Visit – http://www.richtvlive.com/ a community for stocks, , news, and trending topics. #richtvlive #stockmarket #money

2 Free Stocks are Waiting for You Valued up to $1400!
Come and gain access to in-depth analytics and low costs at Webull with me – https://act.webull.com/kol-us/share.html?hl=en&inviteCode=k6JClu7x6e2t

Disclaimer

RICH TV LIVE INC. company profiles and other investor relations materials, publications or presentations, including web content, are based on data obtained from sources we believe to be reliable but are not guaranteed as to accuracy and are not purported to be complete. As such, the information should not be construed as advice designed to meet the particular investment needs of any investor. Any opinions expressed in RICH TV LIVE reports company profiles or other investor relations materials and presentations are subject to change. RICH TV LIVE and its affiliates may buy and sell shares of securities or options of the issuers mentioned on this website at any time.

Investing is inherently risky. RICH TV LIVE is not responsible for any gains or losses that result from the opinions expressed on this website, in its research reports, company profiles or in other investor relations materials or presentations that it publishes electronically or in print. Disclosure – https://www.richtvlive.com/feature-.html

We strongly encourage all investors to conduct their own research before making any investment decision. For more information on stock market investing, visit the Securities and Exchange Commission (“SEC”) at www.sec.gov/Canadian CSA https://www.securities-administrators.ca/.

source

%d bloggers like this: